{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T19:54:24Z","timestamp":1768593264639,"version":"3.49.0"},"reference-count":19,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2023,3,31]]},"DOI":"10.1536\/ihj.22-406","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T22:10:53Z","timestamp":1678831853000},"page":"196-202","source":"Crossref","is-referenced-by-count":4,"title":["Optimal Timing of Serial &lt;sup&gt;18&lt;\/sup&gt;F-Fluoro-2-Deoxyglucose Positron Emission Tomography after Prednisolone Treatment Introduction for Cardiac Sarcoidosis"],"prefix":"10.1536","volume":"64","author":[{"given":"Mitsuo","family":"Ishizuka","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kashimura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Niigata University Graduate School of Medical and Dental Sciences"},{"name":"Department of Advanced Cardiopulmonary Vascular Therapeutics, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Kase","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Okubo","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Fujiki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsugumi","family":"Takayama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Ishihara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Inomata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Niigata University Graduate School of Medical and Dental Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. American Thoracic Society (ATS), the European Respiratory Society (ERS), the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG). Statement on sarcoidosis. Am J Respir Crit Care Med 1999; 160: 736-55.","DOI":"10.1164\/ajrccm.160.2.ats4-99"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Terasaki F, Azuma A, Anzai T, <i>et al<\/i>. JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis - digest version. Circ J 2019; 83: 2329-88.","DOI":"10.1253\/circj.CJ-19-0508"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Yazaki Y, Isobe M, Hiroe M, <i>et al<\/i>. Central Japan Heart Study Group. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001; 88: 1006-10.","DOI":"10.1016\/S0002-9149(01)01978-6"},{"key":"4","unstructured":"4. Hiramitsu S, Morimoto S, Uemura A, <i>et al<\/i>. National survey on status of steroid therapy for cardiac sarcoidosis in Japan. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22: 210-3."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Padala SK, Peaslee S, Sidhu MS, <i>et al<\/i>. Impact of early initiation of corticosteroid therapy on cardiac function and rhythm in patients with cardiac sarcoidosis. Int J Cardiol 2017; 227: 565-70.","DOI":"10.1016\/j.ijcard.2016.10.101"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ning N, Guo HH, Iagaru A, Mittra E, Fowler M, Witteles R. Serial cardiac FDG-PET for the diagnosis and therapeutic guidance of patients with cardiac sarcoidosis. J Card Fail 2019; 25: 307-11.","DOI":"10.1016\/j.cardfail.2019.02.018"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Shelke AB, Aurangabadkar HU, Bradfield JS, Ali Z, Kumar KS, Narasimhan . Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis. Int J Cardiol 2017; 228: 717-22.","DOI":"10.1016\/j.ijcard.2016.11.142"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Trivieri MG, Spagnolo P, Birnie D, <i>et al<\/i>. Challenges in cardiac and pulmonary sarcoidosis: JACC state-of-the-art review. J Am Coll Cardiol 2020; 76: 1878-901.","DOI":"10.1016\/j.jacc.2020.08.042"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Osborne MT, Hulten EA, Singh A, <i>et al<\/i>. Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol 2014; 21: 166-74.","DOI":"10.1007\/s12350-013-9828-6"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Chareonthaitawee PC, Beanlands RS, Chen W, <i>et al<\/i>. Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Cardiol 2017; 24: 1741-58.","DOI":"10.1007\/s12350-017-0978-9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Pei-Ing Lee, Gang Cheng, Abass Alavi. The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis. J Nucl Cardiol 2017; 24: 19-28.","DOI":"10.1007\/s12350-016-0682-1"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Yamamoto A, Nagao M, Watanabe E, <i>et al<\/i>. Prognosis and recurrence in cardiac sarcoidosis: Serial assessment of BMIPP SPECT and FDG-PET. J Nucl Cardiol 2021; 28: 919-29.","DOI":"10.1007\/s12350-021-02567-0"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Yokoyama R, Miyagawa M, Okayama H, <i>et al<\/i>. Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET\/CT for detection of cardiac sarcoidosis. Int J Cardiol 2015; 195: 180-7.","DOI":"10.1016\/j.ijcard.2015.05.075"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Yokoyama R, Miyagawa M, Okayama H, <i>et al<\/i>. Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET\/CT for detection of cardiac sarcoidosis. Int J Cardiol 2015; 195: 180-7.","DOI":"10.1016\/j.ijcard.2015.05.075"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yazaki Y, Isobe M, Hiroe M, <i>et al<\/i>. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001; 88: 1006-10.","DOI":"10.1016\/S0002-9149(01)01978-6"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Werner RA, Wakabayashi H, Bauer J, <i>et al<\/i>. Longitudinal 18F-FDG PET imaging in a rat model of autoimmune myocarditis. Eur Heart J Cardiovasc Imaging 2019; 20: 467-74.","DOI":"10.1093\/ehjci\/jey119"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Minamimoto R. Series of myocardial FDG uptake requiring considerations of myocardial abnormalities in FDG-PET\/CT. Jpn J Radiol 2021; 39: 540-57.","DOI":"10.1007\/s11604-021-01097-6"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Singh JA, Saag KG, Bridges SL Jr, <i>et al<\/i>. 2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 2016; 68: 1-26.","DOI":"10.1002\/art.39480"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Oliveira M, Palacios-Fernandez S, Cervera R, Espinosa G. Clinical practice guidelines and recommendations for the management of patients with systemic lupus erythematosus: a critical comparison. Rheumatology 2020; 59: 3690-9.","DOI":"10.1093\/rheumatology\/keaa142"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/64\/2\/64_22-406\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T05:05:36Z","timestamp":1715317536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/64\/2\/64_22-406\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.22-406","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,31]]},"article-number":"22-406"}}